Early and intermediate age-related macular degeneration: update and clinical review
Alfredo García-Layana,1–3 Francisco Cabrera-López,4,5 José García-Arumí,6–8 Lluís Arias-Barquet,9,10 José M Ruiz-Moreno3,11,12 1Department of Ophthalmology, Clínica Universidad de Navarra, Pa...
Saved in:
Main Authors: | García-Layana A, Cabrera-López F, García-Arumí J, Arias-Barquet L, Ruiz-Moreno JM |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/d731c77c78f34c34861df8da6f0fe0b4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
by: Canan H, et al.
Published: (2014) -
Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
by: Hanan ElShelmani, et al.
Published: (2021) -
The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
by: Varano M, et al.
Published: (2016) -
Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
by: Cui C, et al.
Published: (2017) -
Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
by: Amoaku W, et al.
Published: (2018)